PI
BBIO icon

PFG Investments’s BridgeBio Pharma BBIO Stock Holding History

PFG Investments’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$978K Buy
13,125
+5,400
+70% +$378K 0.04% 401
2026
Q1 		$574K Buy
7,725
+2,275
+42% +$165K 0.03% 551
2025
Q4 		$417K Sell
5,450
-100
-2% -$6.56K 0.02% 643
2025
Q3 		$288K Sell
5,550
-350
-6% -$17.1K 0.02% 809
2025
Q2 		$255K Buy
+5,900
New +$215K 0.01% 808

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

PFG Investments's BBIO Position: Q2 2026 in Review

PFG Investments increased its BridgeBio Pharma (BBIO) stake by 70% in Q2 2026, buying an estimated $378K and bringing the position to 13,125 shares worth $978K. The position accounts for 0.04% of the portfolio, ranked #401.

PFG Investments first reported a position in BBIO in Q2 2025 and has held it in 5 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • PFG Investments held 13,125 shares of BridgeBio Pharma worth $978K as of Q2 2026.
  • PFG Investments bought 5,400 BridgeBio Pharma shares in Q2 2026, an estimated $378K.
  • BridgeBio Pharma made up 0.04% of PFG Investments's portfolio in Q2 2026, its #401 holding.
  • PFG Investments first reported a position in BridgeBio Pharma in Q2 2025 and has held it in 5 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.